BAO PHARMA-B 02659·

Gross margin 97.85%--81.49%16.36%89.00%7.51% Net margin -2314.50%---5916.12%3601.62%-804.18%5111.94% ROE -21.41%---36.59%15.18%-24.83%11.76% ROA -16.47%---26.73%10.26%-17.83%8.90% Revenue growth -----11.11%--697.99%709.10% Attributable profit growth -----127.21%---8.47%118.74% Debt-to-assets 23.08%--26.95%3.87%28.19%1.24% Current ratio 2.49--3.390.904.120.73 Operating cash flow / net profit 0.87--0.600.270.460.15 Operating cash flow / revenue -2023.28%---3567.87%1544.60%-366.28%3201.59%

Gross margin 99.37%--94.56%4.81% Net margin -436.05%---1556.30%1120.26% Revenue growth -----76.48%-- Attributable profit growth ----16.06%-- Debt-to-assets ----33.23%-- Current ratio ----3.85-- Operating cash flow / net profit 0.57--0.950.38 Operating cash flow / revenue -250.51%---1484.78%1234.27%

Revenue 6.93M--6.16M11.11%49.16M697.99% Other income and gains 17.60M--7.60M56.79%16.98M123.25% Gross profit 6.78M--5.02M25.97%43.75M771.53% Selling and distribution expenses 1.23M--7.91M544.50%6.62M16.27% Administrative expenses 46.35M--107.64M132.22%104.61M2.81% Net finance costs 3.65M--4.56M24.65%5.97M31.12% Income tax 1.00K--23.00K2200.00%---- Operating profit -155.83M---359.29M130.57%-389.09M8.29% Share of associates and JVs -915.00K---609.00K33.44%-238.00K60.92% Profit before tax -160.40M---364.46M127.22%-395.30M8.46% Net profit -160.40M---364.43M127.21%-395.30M8.47% Net profit attributable to owners -160.40M---364.43M127.21%-395.30M8.47%

Revenue 41.99M--9.88M76.48% Other income and gains 5.90M--12.25M107.73% Cost of sales 265.00K--537.00K102.64% Gross profit 41.73M--9.34M77.62% Administrative expenses 46.15M--40.62M12.00% Net finance costs 2.67M--3.09M15.83% Income tax 0--0-- Share of associates and JVs -114.00K---54.00K52.63% Profit before tax -183.10M---153.69M16.06% Net profit -183.10M---153.69M16.06% Net profit attributable to owners -183.10M---153.69M16.06%

Cash and cash equivalents 321.67M--524.16M62.95%1.24B136.88% Trade and bills receivables 2.00M--141.00K92.95%98.00K30.50% Inventories 8.07M--4.71M41.59%6.25M32.51% Total current assets 366.14M--665.58M81.78%1.36B104.81% Total assets 973.88M--1.36B39.98%2.22B62.62% Total current liabilities 146.82M--196.23M33.65%330.65M68.50% Total liabilities 224.75M--367.39M63.46%625.00M70.12% Equity attributable to owners 749.13M--995.88M32.94%1.59B59.86% Total equity 749.13M--995.88M32.94%1.59B59.86%

Cash and cash equivalents ----1.04B-- Trade and bills receivables ----6.91M-- Inventories ----16.78M-- Total current assets ----1.21B-- Total assets ----2.17B-- Total current liabilities ----314.72M-- Total liabilities ----721.11M-- Equity attributable to owners ----1.45B-- Total equity ----1.45B--

Net cash from operating activities -140.21M---219.78M56.75%-180.05M18.08% Net cash from investing activities -136.37M---122.12M10.45%-92.96M23.88% Net cash from financing activities 122.93M--543.20M341.86%998.03M83.73% Net change in cash -153.65M--201.29M231.01%725.02M260.18%

Net cash from operating activities -105.19M---146.62M39.39% Net cash from investing activities -29.82M---116.18M289.59% Net cash from financing activities 64.53M--99.16M53.67% Net change in cash -70.48M---163.64M132.17%